Aerial Biopharma announce positive Phase II results for narcolepsy drug

A new drug to treat excessive daytime sleepiness associated with narcolepsy has shown positive results from a phase 2b clinical trial, US-based Aerial Biopharma has announced this week.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news